Copyright © 2002 by the European Society of Cardiology.
Letters To The Editor
A reply
University Hospital, Linkoping Heart Center, Linkoping, Sweden
References
- Lancet. 1999;354:708715[CrossRef][ISI][Medline]
- Lancet. 1999;354:701707[CrossRef][ISI][Medline]
- Wallentin L, Lagerqvist B, Husted S, Kontny F, St
hle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356:916[CrossRef][ISI][Medline]
- Diderholm E, Andrén B, Frostfeldt G. The prognostic and therapeutic implications of increased Troponin T levels and ST depression in unstable coronary artery diseasethe FRISC II invasive Troponin T-ECG substudy. Am Heart J. 2002;143:760767[CrossRef][ISI][Medline]
- Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. J Am Med Assoc. 2001;286:21072113
[Abstract/Free Full Text] - Socialstyrelsen, Nationella riktlinjer för v
rd av kranskärlssjukdom, Stockholm, Socialstyrelsen, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||